J2KBIO Co., Ltd. (KOSDAQ:420570)
South Korea · Delayed Price · Currency is KRW 9,480.00
-90.00 (-0.94%)
Last updated: Sep 16, 2025, 12:54 PM KST
J2KBIO Revenue
J2KBIO had revenue of 8.53B KRW in the quarter ending June 30, 2025, a decrease of -29.18%. This brings the company's revenue in the last twelve months to 29.07B, down -19.06% year-over-year. In the year 2024, J2KBIO had annual revenue of 33.13B with 16.36% growth.
Revenue (ttm)
29.07B
Revenue Growth
-19.06%
P/S Ratio
1.93
Revenue / Employee
538.41M
Employees
54
Market Cap
56.02B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 33.13B | 4.66B | 16.36% |
| Dec 31, 2023 | 28.47B | 12.44B | 77.60% |
| Dec 31, 2022 | 16.03B | 1.81B | 12.75% |
| Dec 31, 2021 | 14.22B | 360.95M | 2.60% |
| Dec 31, 2020 | 13.86B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 308.59T |
| SK hynix | 77.21T |
| LG Energy Solution | 25.16T |
| Samsung Biologics | 5,031.69B |
| Hanwha Aerospace | 19.25T |
| Hyundai Motor Company | 182.25T |
| HD Hyundai Heavy Industries | 15.58T |
| KB Financial Group | 14.92T |